Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies
Open Access
- 13 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 13 (1), 1-13
- https://doi.org/10.1186/s13098-021-00695-8
Abstract
COVID-19 has stroke Brazil harshly, deaths by COVID-19 in Brazil represent almost 13% of the total deaths by COVID-19 in the world, even though Brazilian population represents only 2.6% of the world population. Our aim in this study was to evaluate death and intubation outcomes and risk factors associated with COVID-19, and treatment options focusing on diabetes patients and the use of metformin pre-admission and during hospitalization. In this Brazilian single-center study we evaluated 1170 patients hospitalized due to COVID-19. Diabetes patients (n = 188) were divided based on their use of pre-hospital and in-hospital metformin (non-met-group and met-group). In the total cohort most comorbidities were risk factors for orotracheal intubation and death. The use of chloroquine/hydroxychloroquine was significantly associated with increased death and intubation risk in uni- and multivariate analysis. Diabetes patients showed worst clinical feature compared with non-diabetes patients. In-hospital non-met-group had increased mortality (20.5%) compared to met-group (3.5%) (p = 0.0002) and univariable cox proportion hazard regression indicated in-hospital metformin reduced mortality (HR = 0.325, p = 0.035). Patients that used pre-hospital metformin showed lower severity parameters at hospital admission. (met-group: 2.45 ± 2.5; non-met-group: 4.25 ± 3.4). In all the groups older patients showed more severe clinical conditions and high risk of death and intubation. Even though this is a single-center study, results from other reports have shown a similar trend, indicating that patients that used metformin during hospitalization have a better prognosis and reduced risk of death.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/15619-2; 2020/08271-7)
This publication has 48 references indexed in Scilit:
- Metformin and COVID‐19: A novel deal of an old drugJournal of Medical Virology, 2020
- Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatoryDiabetes Research and Clinical Practice, 2020
- Letter to the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategyMetabolism, 2020
- Clinical characteristics and outcomes of patients with severe covid-19 with diabetesBMJ Open Diabetes Research & Care, 2020
- Practical recommendations for the management of diabetes in patients with COVID-19The Lancet Diabetes & Endocrinology, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Metformin: Ongoing Journey with Superdrug RevolutionAdvanced Pharmaceutical Bulletin, 2019
- Update on off label use of metformin for obesityPrimary Care Diabetes, 2018
- Hypothesis links emergence of chloroquine-resistant malaria and other intracellular pathogens and suggests a new strategy for treatment of diseases caused by intracellular parasitesMedical Hypotheses, 2004
- An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous virusesVaccine, 1995